{"doi":"10.1586/era.09.119","title":"HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment","abstract":null,"journal":"Expert Review of Anticancer Therapy","year":2009,"id":19442,"datarank":0.7423419989449263,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"self_citation_contribution":0.3596842909197557,"citation_network_contribution":0.3826577080251706,"self_endowment_contribution":0.3596842909197557,"citer_contribution":0.3826577080251706,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":10,"citers_with_citation_signal":9,"citers_with_endowment":9,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":131766,"name":"Jean-Luc Van Laethem","orcid":null,"position":1,"is_corresponding":false},{"id":131765,"name":"Raphaël Maréchal","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":2.3978952727983707,"endowment":2.3978952727983707,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19828005","pmcid":null,"openalex_id":"https://openalex.org/W1974995659","authors":[],"funders":[],"total_grants":0,"fwci":0.2953,"citation_percentile":0.599855,"influential_citations":0,"citation_trend":[{"year":2012,"count":1},{"year":2014,"count":2},{"year":2015,"count":1},{"year":2016,"count":2},{"year":2019,"count":1},{"year":2021,"count":1},{"year":2023,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://www.tandfonline.com/doi/pdf/10.1586/era.09.119?needAccess=true","host_type":"BRONZE"},{"url":"http://www.tandfonline.com/doi/pdf/10.1586/era.09.119","host_type":"publisher"},{"url":"https://doi.org/10.1586/era.09.119","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/19828005","host_type":"repository"},{"url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111384","host_type":"repository"}],"fields_of_study":["Pancreatic and Hepatic Oncology Research","Renal and related cancers","Epigenetics and DNA Methylation","Medicine","Antigens, Surface","Antimetabolites, Antineoplastic","Carcinoma, Pancreatic Ductal","Cytoplasm","Deoxycytidine","Deoxycytidine Kinase","ELAV Proteins","ELAV-Like Protein 1","Gene Expression Regulation, Neoplastic","Humans","Pancreatic Neoplasms","Prodrugs","RNA-Binding Proteins","Treatment Outcome","Gemcitabine"],"mesh_terms":["ELAV-Like Protein 1","Gemcitabine","Antigens, Surface","Antimetabolites, Antineoplastic","Cytoplasm","Deoxycytidine","Deoxycytidine Kinase","Humans","Pancreatic Neoplasms","Prodrugs","Gene Expression Regulation, Neoplastic","RNA-Binding Proteins","Treatment Outcome","Carcinoma, Pancreatic Ductal","ELAV Proteins"],"keywords":["Medicine","Gemcitabine","Pancreatic cancer","Oncology","Internal medicine","Cancer","Cancer research"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-04T04:05:20.052670Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}